577 filings
Page 4 of 29
8-K
54ucl3uf mq6wi
9 Nov 20
Altimmune Announces Third Quarter 2020 Financial Results
4:07pm
8-K
a2g4f0e2e
25 Sep 20
Submission of Matters to a Vote of Security Holders
4:05pm
S-8
ljnprnyl
21 Aug 20
Registration of securities for employees
4:05pm
8-K
qeg48pocb1e4a
11 Aug 20
Altimmune Announces Second Quarter 2020 Financial Results and Provides a Business Update
4:07pm
8-K/A
m9p d1mxmx
16 Jul 20
Departure of Directors or Certain Officers
4:57pm
8-K
byn13z637nz
16 Jul 20
Altimmune Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
4:38pm
424B5
rlso0l 74
14 Jul 20
Prospectus supplement for primary offering
9:54pm
424B5
14u 76osogul
13 Jul 20
Prospectus supplement for primary offering
4:06pm
8-K
dw3tyjol
13 Jul 20
AdCOVID stimulated both strong serum neutralizing activity and potent mucosal immunity (IgA) in the respiratory tract
7:11am
424B5
zgyj7q ufpwkh99oem
1 Jun 20
Prospectus supplement for primary offering
7:18am
8-K
hvh6 ik0017
1 Jun 20
Altimmune Launches Clinical Trial ofT-COVIDTM, an Investigational Intranasal
7:07am
8-K
gizpxz i2yark
13 May 20
Altimmune Announces First Quarter 2020 Financial Results and Provides a Business Update
5:20pm
8-K
ttgahvis fi9tg
12 May 20
Altimmune Appoints Former Pfizer and GSK Executive Diane Jorkasky, M.D. to its Board of Directors
7:30am
8-K
nw11sj7
8 Apr 20
Entry into a Material Definitive Agreement
8:00am
8-K
6uqqiz8z639yg6
27 Mar 20
Entry into a Material Definitive Agreement
4:08pm
424B5
lapheg
27 Mar 20
Prospectus supplement for primary offering
7:47am